Registered entities
Spark Therapeutics, Inc.
Reg. No. 1609351United States
Innovation
55 patent families (14 granted) — focus: Chemistry & metallurgy, Human necessities, Operations & transport, Physics & computing; filing pace accelerating. Cited 1,399 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 9 |
| 2019 | 16 |
| 2020 | 15 |
| 2021 | 19 |
| 2022 | 19 |
| 2023 | 22 |
| 2024 | 29 |
| 2025 | 38 |
| 2026 | 13 |
Investor mix
8 investors on record; lead investors include Sofinnova Investments.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 50% |
| Bank & private debt | 1 | 13% |
| Other / undisclosed | 3 | 38% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
3 Sep 2024 · Medical Affairs Fellow · Philadelphia
3 Sep 2024 · TMF Quality Control Specialist · Philadelphia
29 Aug 2024 · Research Associate - Upstream Process Development · Philadelphia
20 Aug 2024 · PD Downstream Scientist · Philadelphia
14 Aug 2024 · Sr. Director, Biostatistics & Statistical Programming · Philadelphia
Based on job postings tracked across public sources.